Keeping you up to date on recent developments in orthopedics, including: Bone or cartilage? Presence of fatty acids determines skeletal stem cell development; A promising new strategy to help broken bones heal faster; Drug cocktail holds promise for spinal injuries.
The U.S. Centers for Medicare and Medicaid Services (CMS) announced it may tack on another three years to the Comprehensive Care for Joint Replacement (CJR) program, proposing among other things to drop the 50% cap on gainsharing payments. Analysts with Cowen Washington Research Group, of New York, said post-acute care providers are at greater risk than device makers with the extension, however, due to the fact that hospitals have several choices in terms of discharge destination, including the patient’s home.
Keeping you up to date on recent developments in orthopedics, including: In2bones reports U.S. Launch of the Avenger radial head prosthesis; Searching for biomarkers and therapeutic agents against breast cancer; MRI findings predict shoulder stiffness for rotator cuff tears.
PERTH, Australia – Brisbane, Australia-based Field Orthopaedics was formed when a group of orthopedic surgeons were exasperated by ongoing shortcomings in surgical practice and decided to do something about it.
Keeping you up to date on recent developments in orthopedics, including: Using bone’s natural electricity to promote regeneration; Puregraft reports successful phase IIa trial results for KO; Bioventus updates U.S. label for Exogen ultrasound bone healing system; Injectable drug for faster healing of bone fractures prepares for clinical trials (Novosteo).
Keeping you up to date on recent developments in orthopedics, including: After a bone injury, shape-shifting cells rush to the rescue; Machine-learning tool identified predictive factors associated with worse patient outcomes after arthroscopic hip surgery; New injection technique may boost spinal cord injury repair efforts; Does tramadol increase hip fracture risk?
Zimmer Biomet Holdings Inc., of Warsaw, Ind., reported good news for the fourth quarter, which saw net sales of $2.126 billion, an increase of 2.6% over the prior year period. In terms of geography, the Americas and Asia-Pacific stood out. In addition, the company witnessed strong results globally in its knee and hip businesses.
Stryker Corp., of Kalamazoo, Mich., saw strength in the fourth quarter, with Mako experiencing good uptake in total knee arthroplasty. Katherine Owen, Stryker’s vice president of strategy & investor relations, said Mako demand was driven by the benefits of its robotic technology, multiple applications and the ability to do cementless knee.
Keeping you up to date on recent developments in orthopedics, including: Tiny salamander's huge genome may harbor the secrets of regeneration; New injection technique may boost spinal cord injury repair efforts; ACL tears cause harmful changes in brain structure
RSS
